Jeff Yass’s Sana Biotechnology SANA Stock Holding History

Jeff Yass’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$517K	Buy	148,200 +74,300	+101%	+$239K	﹤0.01%	9849
2026 Q1	$213K	Sell	73,900 -45,300	-38%	-$178K	﹤0.01%	11564
2025 Q4	$485K	Sell	119,200 -12,300	-9%	-$55.1K	﹤0.01%	8858
2025 Q3	$467K	Buy	131,500 +1,100	+0.8%	+$3.98K	﹤0.01%	9122
2025 Q2	$356K	Sell	130,400 -6,700	-5%	-$13.8K	﹤0.01%	9959
2025 Q1	$230K	Buy	137,100 +71,500	+109%	+$200K	﹤0.01%	10638
2024 Q4	$107K	Sell	65,600 -46,400	-41%	-$138K	﹤0.01%	11293
2024 Q3	$466K	Buy	112,000 +22,600	+25%	+$119K	﹤0.01%	8626
2024 Q2	$488K	Sell	89,400 -3,300	-4%	-$26.3K	﹤0.01%	8326
2024 Q1	$927K	Buy	+92,700	New	+$694K	﹤0.01%	7095
2022 Q3	–	Sell	-16,200	Closed	-$104K	–	13998
2022 Q2	$104K	Buy	16,200 +1,200	+8%	+$7.64K	﹤0.01%	11444
2022 Q1	$124K	Buy	15,000 +2,500	+20%	+$20.2K	﹤0.01%	11749
2021 Q4	$194K	Buy	+12,500	New	+$241K	﹤0.01%	11482

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jeff Yass's SANA Position: Q2 2026 in Review

Jeff Yass reduced its Sana Biotechnology (SANA) stake by 8.9% in Q2 2026, selling an estimated $121K and leaving 384,083 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #7450.

Jeff Yass first reported a position in SANA in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.28M in Q4 2025. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Jeff Yass held 384,083 shares of Sana Biotechnology worth $1.34M as of Q2 2026.
Jeff Yass sold 37,472 Sana Biotechnology shares in Q2 2026, an estimated $121K.
Sana Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7450 holding.
Jeff Yass first reported a position in Sana Biotechnology in Q2 2021 and has held it in 21 quarters since.
Jeff Yass's Sana Biotechnology position peaked at $2.28M in Q4 2025.
208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.